Immunotherapy with nebulized pattern recognition receptor agonists restores severe immune paralysis and improves outcomes in mice with influenza-associated pulmonary aspergillosis
Jezreel Pantaleón García(The University of Texas MD Anderson Cancer Center), Scott E. Evans(The University of Texas MD Anderson Cancer Center), Keerthi Bhoda(The University of Texas MD Anderson Cancer Center), Mbaya Ntita(The University of Texas MD Anderson Cancer Center), Sebastian Wurster(The University of Texas MD Anderson Cancer Center), Dimitrios P. Kontoyiannis(The University of Texas MD Anderson Cancer Center), Yongxing Wang(The University of Texas MD Anderson Cancer Center), Madeleine Burch-Eapen(The University of Texas MD Anderson Cancer Center), Daniela Covarrubias López(The University of Texas MD Anderson Cancer Center), Nathaniel D. Albert(The University of Texas MD Anderson Cancer Center), Uddalak Bharadwaj(Michael E. DeBakey VA Medical Center), Paris Rodríguez Carstens(The University of Texas MD Anderson Cancer Center), V. Kulkarni(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k
Epidemiology and Clinical Manifestations of Mucormycosis
|Clinical Infectious Diseases|2012|1.5k